Monitoring of NOAC Therapy: Standardizing Reference Intervals

Non-warfarin Oral AntiCoagulant Resumption After Gastrointestinal Bleeding in Atrial Fibrillation Patients

NCT03785080 ·Status: RECRUITING ·Phase: NA

The Association Between Non-vitamin K Antagonist Oral Anticoagulant Therapy and Acute Stroke Severity and Post Stroke Short-term and Long-term Outcomes.

NCT05283174 ·Status: RECRUITING

Predictive Factors for Response to New Oral Anticoagulants in the Treatment of Non-valvular Atrial Fibrillation..

NCT04297150 ·Status: UNKNOWN

Comparison of Efficacy and Safety Among Dabigatran, Rivaroxaban, and Apixaban in Non-Valvular Atrial Fibrillation

NCT02666157 ·Status: UNKNOWN ·Phase: PHASE4

Dabigatran Versus Warfarin With NVAF Who Undergo PCI

NCT03536611 ·Status: UNKNOWN ·Phase: PHASE4

Effectiveness and Safety of Rivaroxaban Used in Extended Anticoagulation for Pulmonary Embolism Patients

NCT04527042 ·Status: UNKNOWN

Comparative Effectiveness and Safety Between Warfarin and Dabigatran

NCT03254134 ·Status: COMPLETED

Pleotropic Effect of New Oral Anticoagulants

NCT02544932 ·Status: UNKNOWN ·Phase: PHASE3

Real-World Comparative Observational Study in Non-Valvular Atrial Fibrillation Patients Using Oral Anticoagulants

NCT02754154 ·Status: COMPLETED

Safety and Efficacy of Edoxaban and Rivaroxaban to Cerebral Venous Thrombosis in Chinese Patients

NCT06947707 ·Status: RECRUITING

Effectiveness of Combined Anticoagulation and Antithrombotic Therapy vs Antithrombotic Therapy Alone After Lower Extremity Revascularization for Peripheral Arterial Disease

NCT04994223 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

A Prospective Cohort Study on Warfarin Personalized Medication

NCT06428110 ·Status: COMPLETED

A Real-World Comparison of Safety and Effectiveness of Novel Oral Anti-Coagulant (NOAC) Naïve and Warfarin Naïve Non-Valvular Atrial Fibrillation (NVAF) Patients With Medicare Advantage Coverage

NCT03189069 ·Status: COMPLETED

Rivaroxaban Estimation With Warfarin in Atrial Fibrillation Patients With Coronary Stent Implantation Study (REWRAPS)

NCT02024230 ·Status: COMPLETED ·Phase: PHASE4

The Study of Monitoring and Dosing Guidance of Direct Oral Anticoagulants Based on Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics

NCT06362343 ·Status: RECRUITING

Direct Factor Xa Inhibitor YM150 for Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation

NCT00448214 ·Status: COMPLETED ·Phase: PHASE2

Rivaroxaban ACS Specialist Cohort Event Monitoring Study

NCT02673437 ·Status: COMPLETED

An Observational Post-Authorization Safety Specialist Cohort Event Monitoring Study (SCEM) to Monitor the Safety and Utilization of Rivaroxaban (Xarelto®).

NCT01871194 ·Status: COMPLETED

Study to Observe Safety of Xarelto in VTE Prophlylaxis After Elective TKR (Total Knee Replacement) or THR (Total Hip Replacement)

NCT01523418 ·Status: WITHDRAWN

Rivaroxaban for Patients With Antiphospholipid Syndrome

NCT02926170 ·Status: COMPLETED ·Phase: PHASE3

Evaluataion of NOAC Levels in Acute Stroke

NCT06144866 ·Status: RECRUITING

Oral Anticoagulant Discontinuation, Adherence Patterns, Hospitalizations and Costs in Non-Valvular Atrial Fibrillation (NVAF) Patients

NCT02792335 ·Status: COMPLETED

Quality of Anticoagulation With Warfarin in Patient With Atrial Fibrillation for Secondary Stroke Prevention in Korea

NCT02810509 ·Status: COMPLETED

Precision Medicine Platform for Novel Oral Anticoagulants

NCT04056143 ·Status: UNKNOWN

A Study of BIBR 1048 in Prevention of Venous Thromboembolism in Patients With TKR Surgery.

NCT00246025 ·Status: COMPLETED ·Phase: PHASE2